넥스겔 (NXGL) 주가

넥스겔(NXGL)는 NAS에 상장된 Healthcare · Medical Instruments & Supplies 기업입니다. 현재가 $0.27 (+7.05%), 시가총액 $4.93M.

NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment.

핵심 지표

• 현재가: $0.27 (+7.05%)
• 시가총액: $4.93M
• 섹터: Healthcare
• 산업: Medical Instruments & Supplies
• 거래소: NAS

넥스겔의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.

넥스겔 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 매수 (4.0 / 5)

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 1.13
• 순이익률: -26.27%
• 영업이익률: -43.42%

자주 묻는 질문